IndraLab

Statements


JOSD2 deubiquitinates PRMT5. 1 / 1
| 1

reach
"PRMT5’s role in various malignancies implies that it is likely a key substrate protein for JOSD2's oncogenic function, and JOSD2's deubiquitination of PRMT5 may have significant implications for the treatment of ESCC."